Tags: MDMAecstasyPTSD therapydementiadepression
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Kristen Monaco MedPage Today | Psychedelics for Psych Conditions Made Their Mark in 2023 - 4 months ago | |
| 2 | Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA | ||
| 3 | Lev Facher STAT News | ||
| 4 | Rachel Nuwer Business Insider | ||
| 5 | Anne Thomas Hooper, PharmD candidate 2024 Pharmacy Times | ||
| 6 | Maddie Cheak, PharmD candidate 2024 Pharmacy Times | ||
| 7 | Marilyn Bulloch, PharmD, BCPS Pharmacy Times | ||
| 8 | Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. | MDMA—aka ecstasy—submitted to FDA as part of PTSD therapy - 5 months ago | |
| 9 | Pharmaceutical Executive Editorial Staff Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey | ||
| 10 | Charles Bankhead MedPage Today |